US Stock MarketDetailed Quotes

Theriva Biologics (TOVX)

Watchlist
  • 0.3210
  • -0.0090-2.73%
Close May 14 16:00 ET
  • 0.3208
  • -0.0002-0.06%
Post 19:21 ET
14.73MMarket Cap-0.55P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Theriva Biologics (TOVX) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Total revenue
300K
0
0
0
0
0
0
0
0
0
Operating revenue
--300K
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-45.05%2.43M
23.80%24.05M
-54.96%2.06M
-11.83%4.44M
197.10%13.13M
-18.08%4.42M
-9.35%19.43M
-26.33%4.58M
19.39%5.04M
-24.05%4.42M
Selling and administrative expenses
43.00%2.07M
108.86%15.45M
-45.04%931K
-17.94%1.89M
662.03%11.18M
-25.04%1.45M
3.88%7.4M
-16.18%1.69M
985.85%2.3M
-45.40%1.47M
-General and administrative expense
43.00%2.07M
108.86%15.45M
-45.04%931K
-17.94%1.89M
662.03%11.18M
-25.04%1.45M
3.88%7.4M
-16.18%1.69M
985.85%2.3M
-45.40%1.47M
Research and development costs
-88.04%355K
-28.48%8.6M
-60.78%1.13M
-6.69%2.55M
-33.86%1.95M
-14.19%2.97M
-15.93%12.03M
-31.22%2.89M
-31.75%2.73M
-5.75%2.95M
Operating profit
51.85%-2.13M
-23.80%-24.05M
54.96%-2.06M
11.83%-4.44M
-197.10%-13.13M
18.08%-4.42M
9.35%-19.43M
26.33%-4.58M
-19.39%-5.04M
24.05%-4.42M
Net non-operating interest income expense
-14.58%82K
-58.82%287K
-47.83%72K
-58.86%65K
-68.79%54K
-57.89%96K
-51.56%697K
-55.77%138K
-58.64%158K
-54.59%173K
Non-operating interest income
-14.58%82K
-58.82%287K
-47.83%72K
-58.86%65K
-68.79%54K
-57.89%96K
-51.56%697K
-55.77%138K
-58.64%158K
-54.59%173K
Other net income (expense)
133.33%1K
100.36%25K
0.00%-5K
100.49%14K
100.49%20K
-200.00%-3K
-230,866.67%-6.92M
-25.00%-5K
-47,566.67%-2.85M
-101,625.00%-4.07M
Gain on sale of security
133.33%1K
725.00%25K
0.00%-5K
366.67%14K
2,100.00%20K
-200.00%-3K
-233.33%-4K
-25.00%-5K
-50.00%3K
75.00%-1K
Special income (charges)
----
--0
--0
--0
--0
----
---6.92M
--0
---2.85M
---4.07M
-Less:Impairment of capital assets
----
--0
--0
--0
--0
----
--5.59M
--0
--1.53M
--4.07M
-Write off
----
--0
--0
--0
----
----
--1.33M
--0
--1.33M
----
Income before tax
52.73%-2.04M
7.46%-23.74M
55.12%-2M
43.55%-4.36M
-57.02%-13.06M
16.28%-4.32M
-28.34%-25.65M
24.74%-4.45M
-101.72%-7.73M
-52.78%-8.32M
Income tax
0
0
0
0
0
0
0
0
0
0
Net income
52.73%-2.04M
7.46%-23.74M
55.12%-2M
43.55%-4.36M
-57.02%-13.06M
16.28%-4.32M
-39.81%-25.65M
18.92%-4.45M
-133.91%-7.73M
-63.57%-8.32M
Net income continuous Operations
52.73%-2.04M
7.46%-23.74M
55.12%-2M
43.55%-4.36M
-57.02%-13.06M
16.28%-4.32M
-39.81%-25.65M
18.92%-4.45M
-133.91%-7.73M
-63.57%-8.32M
Minority interest income
Net income attributable to the parent company
52.73%-2.04M
7.46%-23.74M
55.12%-2M
43.55%-4.36M
-57.02%-13.06M
16.28%-4.32M
-39.81%-25.65M
18.92%-4.45M
-133.91%-7.73M
-63.57%-8.32M
Preferred stock dividends
Other preferred stock dividends
1.51M
0
Net income attributable to common stockholders
52.73%-2.04M
1.57%-25.25M
21.16%-3.51M
43.55%-4.36M
-57.02%-13.06M
16.28%-4.32M
-39.81%-25.65M
18.92%-4.45M
-133.91%-7.73M
-63.57%-8.32M
Basic earnings per share
96.77%-0.05
89.07%-2.08
93.85%-0.0982
93.39%-0.45
82.00%-1.93
79.42%-1.55
33.18%-19.03
80.27%-1.5982
-40.41%-6.81
-26.12%-10.72
Diluted earnings per share
96.77%-0.05
89.07%-2.08
93.85%-0.0982
93.39%-0.45
82.00%-1.93
79.42%-1.55
33.18%-19.03
80.27%-1.5982
-40.41%-6.81
-26.12%-10.72
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Total revenue 300K000000000
Operating revenue --300K--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -45.05%2.43M23.80%24.05M-54.96%2.06M-11.83%4.44M197.10%13.13M-18.08%4.42M-9.35%19.43M-26.33%4.58M19.39%5.04M-24.05%4.42M
Selling and administrative expenses 43.00%2.07M108.86%15.45M-45.04%931K-17.94%1.89M662.03%11.18M-25.04%1.45M3.88%7.4M-16.18%1.69M985.85%2.3M-45.40%1.47M
-General and administrative expense 43.00%2.07M108.86%15.45M-45.04%931K-17.94%1.89M662.03%11.18M-25.04%1.45M3.88%7.4M-16.18%1.69M985.85%2.3M-45.40%1.47M
Research and development costs -88.04%355K-28.48%8.6M-60.78%1.13M-6.69%2.55M-33.86%1.95M-14.19%2.97M-15.93%12.03M-31.22%2.89M-31.75%2.73M-5.75%2.95M
Operating profit 51.85%-2.13M-23.80%-24.05M54.96%-2.06M11.83%-4.44M-197.10%-13.13M18.08%-4.42M9.35%-19.43M26.33%-4.58M-19.39%-5.04M24.05%-4.42M
Net non-operating interest income expense -14.58%82K-58.82%287K-47.83%72K-58.86%65K-68.79%54K-57.89%96K-51.56%697K-55.77%138K-58.64%158K-54.59%173K
Non-operating interest income -14.58%82K-58.82%287K-47.83%72K-58.86%65K-68.79%54K-57.89%96K-51.56%697K-55.77%138K-58.64%158K-54.59%173K
Other net income (expense) 133.33%1K100.36%25K0.00%-5K100.49%14K100.49%20K-200.00%-3K-230,866.67%-6.92M-25.00%-5K-47,566.67%-2.85M-101,625.00%-4.07M
Gain on sale of security 133.33%1K725.00%25K0.00%-5K366.67%14K2,100.00%20K-200.00%-3K-233.33%-4K-25.00%-5K-50.00%3K75.00%-1K
Special income (charges) ------0--0--0--0-------6.92M--0---2.85M---4.07M
-Less:Impairment of capital assets ------0--0--0--0------5.59M--0--1.53M--4.07M
-Write off ------0--0--0----------1.33M--0--1.33M----
Income before tax 52.73%-2.04M7.46%-23.74M55.12%-2M43.55%-4.36M-57.02%-13.06M16.28%-4.32M-28.34%-25.65M24.74%-4.45M-101.72%-7.73M-52.78%-8.32M
Income tax 0000000000
Net income 52.73%-2.04M7.46%-23.74M55.12%-2M43.55%-4.36M-57.02%-13.06M16.28%-4.32M-39.81%-25.65M18.92%-4.45M-133.91%-7.73M-63.57%-8.32M
Net income continuous Operations 52.73%-2.04M7.46%-23.74M55.12%-2M43.55%-4.36M-57.02%-13.06M16.28%-4.32M-39.81%-25.65M18.92%-4.45M-133.91%-7.73M-63.57%-8.32M
Minority interest income
Net income attributable to the parent company 52.73%-2.04M7.46%-23.74M55.12%-2M43.55%-4.36M-57.02%-13.06M16.28%-4.32M-39.81%-25.65M18.92%-4.45M-133.91%-7.73M-63.57%-8.32M
Preferred stock dividends
Other preferred stock dividends 1.51M0
Net income attributable to common stockholders 52.73%-2.04M1.57%-25.25M21.16%-3.51M43.55%-4.36M-57.02%-13.06M16.28%-4.32M-39.81%-25.65M18.92%-4.45M-133.91%-7.73M-63.57%-8.32M
Basic earnings per share 96.77%-0.0589.07%-2.0893.85%-0.098293.39%-0.4582.00%-1.9379.42%-1.5533.18%-19.0380.27%-1.5982-40.41%-6.81-26.12%-10.72
Diluted earnings per share 96.77%-0.0589.07%-2.0893.85%-0.098293.39%-0.4582.00%-1.9379.42%-1.5533.18%-19.0380.27%-1.5982-40.41%-6.81-26.12%-10.72
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +17.75%
Sample Name
Sample Code
 +15.52%
Sample Name
Sample Code
 +14.53%
4
United States Oil Fund LP
USO
+13.64%
5
Powershares Db Multi-Sector Commodi Powershares Db Oil Fund
DBO
+11.14%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +12.99%
Sample Name
Sample Code
 +9.49%
Sample Name
Sample Code
 +8.77%
4
Hesai
HSAI
+8.01%
5
NIO Inc
NIO
+6.47%
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -